» Articles » PMID: 8342719

Oral Contraceptives and the Risk of Gallbladder Disease: a Meta-analysis

Overview
Specialty Public Health
Date 1993 Aug 1
PMID 8342719
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study was designed to assess the risk of gallbladder disease due to oral contraceptive use by conducting a thorough literature review.

Methods: Controlled epidemiologic studies published through March 1992 were systematically searched and evaluated. Of 25 studies (27 publications), 9 could stand the test of critical appraisal with respect to validity. Restriction to these studies was judged to circumvent publication bias at the same time.

Results: Oral contraceptive use is associated with a slightly and transiently increased rate of gallbladder disease. The results of six selected studies in which asymptomatic women were screened for gallstones were strikingly similar. Pooling of these results yielded an odds ratio, for ever vs never oral contraceptive use, of 1.36. A dose-effect relationship was indicated, suggesting that modern low-dose oral contraceptives are safer than older formulas, but an effect cannot be excluded.

Conclusions: Considering the large efforts already devoted to this exposure-disease relationship, the probably weak effect, and the rapidly changing formulas of oral contraceptives, the authors suggest that the safety of new oral contraceptives be evaluated by studying bile saturation and biliary function rather than by waiting for gallbladder disease to develop.

Citing Articles

Acute cholecystitis in pregnant women: A therapeutic challenge in a developing country center.

Mahjoubi M, Ben Dhaou A, Maatouk M, Essid N, Rezgui B, Karoui Y Ann Hepatobiliary Pancreat Surg. 2023; 27(4):388-393.

PMID: 37915236 PMC: 10700939. DOI: 10.14701/ahbps.23-031.


NMR spectroscopy-based analysis of gallstones of cancerous and benign gallbladders from different geographical regions of the Indian subcontinent.

Siddiqui M, Dwivedi N, Siddiqui M, Rana S, Sharma A, Dash N PLoS One. 2023; 18(6):e0286979.

PMID: 37352214 PMC: 10289436. DOI: 10.1371/journal.pone.0286979.


Risk factors for gallstone disease onset in Japan: Findings from the Shizuoka Study, a population-based cohort study.

Higashizono K, Nakatani E, Hawke P, Fujimoto S, Oba N PLoS One. 2022; 17(12):e0274659.

PMID: 36584097 PMC: 9803237. DOI: 10.1371/journal.pone.0274659.


Demographic and Risk Factor Profile in Patients of Gallstone Disease in Central India.

Patel A, Yeola M, Mahakalkar C Cureus. 2022; 14(5):e24993.

PMID: 35719762 PMC: 9190443. DOI: 10.7759/cureus.24993.


Demographic, Chemical, and Positivity Assessment in Different Types of Gallstones and the Bile in a Random Sample of Cholecystectomied Iranian Patients with Cholelithiasis.

Jahantab M, Safaripour A, Hassanzadeh S, Yavari Barhaghtalab M Can J Gastroenterol Hepatol. 2021; 2021:3351352.

PMID: 34422710 PMC: 8371640. DOI: 10.1155/2021/3351352.


References
1.
HOWAT J, Jones C, Schofield P . Gall-stones and oral contraceptives. J Int Med Res. 1975; 3(2):59-62. DOI: 10.1177/030006057500300201. View

2.
STOLLEY P, Tonascia J, Tockman M, SARTWELL P, RUTLEDGE A, Jacobs M . Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol. 1975; 102(3):197-208. DOI: 10.1093/oxfordjournals.aje.a112148. View

3.
Miettinen O . Estimability and estimation in case-referent studies. Am J Epidemiol. 1976; 103(2):226-35. DOI: 10.1093/oxfordjournals.aje.a112220. View

4.
Vessey M, DOLL R, Peto R, Johnson B, Wiggins P . A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976; 8(4):373-427. DOI: 10.1017/s0021932000010890. View

5.
Bennion L, Grundy S . Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med. 1978; 299(21):1161-7. DOI: 10.1056/NEJM197811232992104. View